Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 53Neoplasms 44Prostatic Neoplasms 43Breast Neoplasms 38Neoplasm Metastasis 21Unspecified Adult Solid Tumor, Protocol Specific 19Lung Neoplasms 18Head and Neck Neoplasms 17Squamous Cell Carcinoma of Head and Neck 16Ovarian Neoplasms 15Advanced Solid Tumors 11Stomach Neoplasms 9Sarcoma 9Pancreatic Neoplasms 9Solid Tumor 8Melanoma 8Esophageal Neoplasms 8Carcinoma, Ovarian Epithelial 8Urinary Bladder Neoplasms 7Fallopian Tube Neoplasms 7Colorectal Neoplasms 7Small Cell Lung Carcinoma 6Salivary Gland Neoplasms 6Esthesioneuroblastoma, Olfactory 5Esophageal Squamous Cell Carcinoma 5Carcinoma, Renal Cell 5Breast Neoplasms, Male 5Triple Negative Breast Neoplasms 4Recurrence 4Endometrial Neoplasms 4

Interventions

pembrolizumab 3atezolizumab 2testosterone 17 beta-cypionate 1temsirolimus 1poly ICLC 1lenvatinib 1enfortumab vedotin 1Valproic Acid 1Testosterone Propionate 1Sunitinib 1Standard of Care 1Sirolimus 1Saline Solution 1Prednisone 1Practice Guidelines as Topic 1Methyltestosterone 1Immunoglobulin G 1Gemcitabine 1GSK-3326595 1Etoposide 1Doxycycline 1Docetaxel 1Disulfides 1Cyclophosphamide 1Cetuximab 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Urologic Neoplasms × Docetaxel × Clear all
NCT01155791 2017-03-15

Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer

Stanford University

Phase 1 Terminated
2 enrolled
Genitourinary

Prostatic Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡